Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 190.40B P/E 30.23 EPS this Y 0.50% Ern Qtrly Grth -51.70%
Income 4.2B Forward P/E 29.24 EPS next Y 13.60% 50D Avg Chg 7.00%
Sales 23.89B PEG 12.84 EPS past 5Y 19.15% 200D Avg Chg 3.00%
Dividend N/A Price/Book 3.68 EPS next 5Y 2.54% 52W High Chg -15.00%
Recommedations 2.00 Quick Ratio 1.28 Shares Outstanding 739.70M 52W Low Chg 17.00%
Insider Own 10.75% ROA 3.98% Shares Float 688.43M Beta 0.86
Inst Own 81.83% ROE 8.15% Shares Shorted/Prior 5.66M/5.80M Price 257.87
Gross Margin 59.14% Profit Margin 19.94% Avg. Volume 3,288,670 Target Price 260.70
Oper. Margin 20.87% Earnings Date Apr 23 Volume 2,545,214 Change 1.13%
About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

DHR Chatroom

User Image DonCorleone77 Posted - 18 hours ago

$DHR Danaher put volume heavy and directionally bearish Bearish flow noted in Danaher with 3,558 puts trading, or 2x expected. Most active are 4/5 weekly 247.5 puts and Apr-24 250 puts, with total volume in those strikes near 1,500 contracts. The Put/Call Ratio is 4.50, while ATM IV is up nearly 2 points on the day. Earnings are expected on April 23rd.

User Image Nosh Posted - 20 hours ago

$COST $DHR Added to cost...about 30% of a position here...DHR started a position again. GLTY.

User Image Latzjan1999 Posted - 21 hours ago

$DHR Looks weak

User Image SimplyP Posted - 3 days ago

$DHR weekly. looks like a good entry right here.

User Image RiskVsReward Posted - 3 days ago

Enjoy folks. Another one to add to your watchlists. $DHR

User Image UncleStock Posted - 3 days ago

$RGLD $AMRK $DHR suggested for #preciousmetals - value screen: https://zpr.io/gQdAr

User Image jaydilks Posted - 5 days ago

@madnessofcrowds I’m with you on this. $GOOG is my #1 fear but a company like $DHR has always been floated in the Rumor Mill. Google would be far more intoxicating for Founders to be allowed to do their thing with a lot of Autonomy and deep pockets. 10% chance but interesting. What Google possess for Cloud Computing power plus Alpha Fold is pretty remarkable. Diversifying to Biology Search for Google would be interesting if done on a massive scale.

User Image SunAndStorm Posted - 5 days ago

$DHR Bought an initial lot based on three separate recommendations, and my view of the price dynamics. It's been outperforming $QQQ despite the current consolidation and has some upward tone in the Opportunity Range™, although at about 71% in the range afterhours (barely up from the close though), so you might get a slightly better price next week. It's a clear 5 month reversal off a major low with 16.1% back to the ATH. Then we'll see... Never any guarantees, and I suggest buying in steps. ;)

User Image Stock_Titan Posted - 6 days ago

$DHR Danaher Schedules First Quarter 2024 Earnings Conference Call https://www.stocktitan.net/news/DHR/danaher-schedules-first-quarter-2024-earnings-conference-3t3s5w3nhh8z.html

User Image Ro_Patel Posted - 1 week ago

CFRA reiterates Buy Rating on $DHR & ups TP from $268 to $279.

User Image UncleStock Posted - 1 week ago

$RGLD $AMRK $DHR suggested for #preciousmetals - value screen: https://zpr.io/gQdAr

User Image jayslow Posted - 1 week ago

$TSVT $GEHC $DHR

User Image Wigglyick Posted - 2 weeks ago

$VLTO Added some today. Wicked below 9ma today but finished above. Price currently above all ma . Good luck. (Spin-off from $DHR ).

User Image briefingcom Posted - 2 weeks ago

$DHR: Danaher's Cepheid receives FDA clearance for Xpert Xpress GBS

User Image noeljefe Posted - 2 weeks ago

$BIOL Biolase would quickly be a profitable business unit (acquisition ) under any of these companies in the dental industry, by simply eliminating bloated departments that could be absorbed into current operations. Keep R&D and support. SG&A are all susceptible: $XRAY $ALGN $MMM $STMN $DHR Dentsply Sirona: Dentsply Sirona is one of the largest manufacturers of dental products and technologies worldwide. Henry Schein: Henry Schein is a leading distributor of healthcare products and services, including dental supplies, equipment, and software solutions. Align Technology: Align Technology is known for its Invisalign system. Danaher Corporation (including KaVo Kerr): Danaher is a multinational conglomerate with a significant presence in the dental industry through its various subsidiaries. 3M Oral Care: 3M Oral Care offers a wide range of dental products, including restorative materials, preventive products, and oral care accessories.

User Image swingingtech Posted - 3 weeks ago

$VTV $QCOM $AMGN $DHR https://wallstreetwaves.com/vanguard-value-etf-experiences-big-inflow/

User Image Patelutsav Posted - 02/29/24

$DHR #stocktowatch #readytobreakout

User Image swingingtech Posted - 4 weeks ago

$VLTO $DHR $ENOV $ESAB https://wallstreetwaves.com/veralto-the-unassuming-esg-powerhouse-that-will-likely-double/

User Image StockInvest_us Posted - 1 month ago

Signal alert: $DHR - Overbought Trend Short (Overvalued) https://stockinvest.us/l/86AmfzynkA

User Image Stock_Titan Posted - 1 month ago

$DHR Danaher to Present at TD Cowen Health Care Conference https://www.stocktitan.net/news/DHR/danaher-to-present-at-td-cowen-health-care-qm6tqsgoh8rb.html

User Image Manipulation13F Posted - 1 month ago

$DHR 👀

User Image Trader_Ty Posted - 1 month ago

$DHR Nice. Might walk the line to ATHs

User Image Fullratio Posted - 1 month ago

$DHR ROE has decreased by 39% YoY and by 20% from the previous quarter: https://fullratio.com/stocks/nyse-dhr/danaher

User Image Towelie Posted - 1 month ago

Danaher hikes dividend by 12.5%. $DHR http://dlvr.it/T34F49

User Image Stock_Titan Posted - 1 month ago

$DHR Danaher Announces Quarterly Dividend https://www.stocktitan.net/news/DHR/danaher-announces-quarterly-c7xwonhhiivl.html

User Image SilverEagle Posted - 1 month ago

$DHR just a beautiful bottom left top right name. Pretty sure we’ll see some of these trend based fib extension targets in 2024.

User Image Latzjan1999 Posted - 1 month ago

$DHR Opinion on the stock?

User Image UncleStock Posted - 1 month ago

$RGLD $AMRK $DHR suggested for #preciousmetals - value screen: https://zpr.io/gQdAr

User Image UncleStock Posted - 1 month ago

$RGLD $AMRK $DHR suggested for #preciousmetals - value screen: https://zpr.io/gQdAr

User Image jaydilks Posted - 1 month ago

$DNA $AMGN is a 156 Billion Market Cap Company that pays a 3.09% Dividend. $DHR is a $181 Billion Market Cap Company with a .39% Dividend. If Ginkgo Bioworks were to receive compensation from either company in the form of shares, which one would you want ?

Analyst Ratings
Keybanc Overweight Feb 1, 24
Citigroup Buy Jan 31, 24
RBC Capital Outperform Jan 31, 24
Raymond James Outperform Jan 31, 24
Barclays Equal-Weight Jan 24, 24
JP Morgan Overweight Dec 20, 23
HSBC Hold Dec 18, 23
Wolfe Research Peer Perform Dec 13, 23
Citigroup Buy Dec 11, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Gutierrez-Ramos Jose-Carlos SVP, Chief Science O.. SVP, Chief Science Officer Aug 21 Sell 250.54 590 147,819 6,939 08/22/23
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jul 26 Sell 263.42 22,439 5,910,881 88,689 07/27/23
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jul 26 Option 56.7 22,439 1,272,291 111,128 07/27/23
List Teri Director Director Jul 26 Sell 263.3 3,490 918,917 17,494 07/27/23
List Teri Director Director Jul 26 Option 50.8 3,490 177,292 20,984 07/27/23
Raskas Daniel SVP - Corporate Deve.. SVP - Corporate Development May 31 Sell 228.5 19,847 4,535,040 38,673 06/01/23
Raskas Daniel SVP - Corporate Deve.. SVP - Corporate Development May 31 Option 57.9 19,847 1,149,141 58,520 06/01/23
LOHR WALTER G Director Director May 05 Sell 240.88 3,490 840,671 12,115 05/08/23
LOHR WALTER G Director Director May 05 Option 50.8 3,490 177,292 15,605 05/08/23
Couchara Georgeann SVP, Human Resources SVP, Human Resources Nov 15 Sell 271.61 1,884 511,713 2,588 11/16/22
McGrew Matthew EVP & Chief Financia.. EVP & Chief Financial Officer Nov 11 Option 57.3 18,935 1,084,976 40,847 11/14/22
McGrew Matthew EVP & Chief Financia.. EVP & Chief Financial Officer Nov 11 Sell 274.67 18,935 5,200,876 29,634 11/14/22
Honeycutt Jennifer Executive Vice Presi.. Executive Vice President Nov 10 Option 65.83 8,211 540,530 15,373 11/14/22
Honeycutt Jennifer Executive Vice Presi.. Executive Vice President Nov 10 Sell 265 8,211 2,175,915 7,162 11/14/22
Blair Rainer President & CEO President & CEO Aug 15 Option 68.29 25,000 1,707,250 104,739 08/17/22
Blair Rainer President & CEO President & CEO Aug 15 Sell 300 25,000 7,500,000 79,739 08/17/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jul 25 Sell 271.56 12,000 3,258,720 74,398 07/26/22
LOHR WALTER G Director Director Jul 22 Option 38.64 4,548 175,735 16,663 07/25/22
LOHR WALTER G Director Director Jul 22 Sell 273.84 3,906 1,069,619 12,115 07/25/22
SCHWIETERS JOHN T Director Director Jul 13 Option 38.64 4,548 175,735 18,663 07/14/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Apr 25 Sell 255.735 6,500 1,662,278 86,398 04/27/22
Ellis Brian W Senior Vice Presiden.. Senior Vice President - GC Feb 02 Sell 293.9884 5,365 1,577,248 12,374 02/03/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jan 31 Option 46.13 20,508 946,034 84,351 02/02/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jan 31 Sell 285.24 20,508 5,849,702 63,843 02/02/22
RALES MITCHELL P Chairman of Exec. Co.. Chairman of Exec. Committee Nov 02 Sell 308.71 1,225,841 378,429,375 11/04/21
LUTZ ROBERT S SVP-Chief Accounting.. SVP-Chief Accounting Officer Oct 27 Option 46.13 24,594 1,134,521 43,544 10/27/20
LUTZ ROBERT S SVP-Chief Accounting.. SVP-Chief Accounting Officer Oct 27 Sell 234.37 24,594 5,764,096 18,950 10/27/20
COMAS DANIEL L EVP EVP Oct 27 Option 65.83 54,402 3,581,284 109,607 10/27/20
COMAS DANIEL L EVP EVP Oct 27 Sell 233.99 54,402 12,729,524 92,683 10/27/20